264 related articles for article (PubMed ID: 28876162)
1. Capacity limits of asialoglycoprotein receptor-mediated liver targeting.
Bon C; Hofer T; Bousquet-Mélou A; Davies MR; Krippendorff BF
MAbs; 2017; 9(8):1360-1369. PubMed ID: 28876162
[TBL] [Abstract][Full Text] [Related]
2. Asialoglycoprotein receptor mediated hepatocyte targeting - strategies and applications.
D'Souza AA; Devarajan PV
J Control Release; 2015 Apr; 203():126-39. PubMed ID: 25701309
[TBL] [Abstract][Full Text] [Related]
3. An internalizing antibody specific for the human asialoglycoprotein receptor.
Trahtenherts A; Benhar I
Hybridoma (Larchmt); 2009 Aug; 28(4):225-33. PubMed ID: 19663694
[TBL] [Abstract][Full Text] [Related]
4. Impaired receptor-mediated endocytosis by the asialoglycoprotein receptor in ethanol-fed mice: implications for studying the role of this receptor in alcoholic apoptosis.
Dalton SR; Wiegert RL; Baldwin CR; Kassel KM; Casey CA
Biochem Pharmacol; 2003 Feb; 65(4):535-43. PubMed ID: 12566080
[TBL] [Abstract][Full Text] [Related]
5. Effective hepatocyte transplantation using rat hepatocytes with low asialoglycoprotein receptor expression.
Ise H; Nikaido T; Negishi N; Sugihara N; Suzuki F; Akaike T; Ikeda U
Am J Pathol; 2004 Aug; 165(2):501-10. PubMed ID: 15277224
[TBL] [Abstract][Full Text] [Related]
6. Physiological roles of asialoglycoprotein receptors (ASGPRs) variants and recent advances in hepatic-targeted delivery of therapeutic molecules via ASGPRs.
Hu J; Liu J; Yang D; Lu M; Yin J
Protein Pept Lett; 2014; 21(10):1025-30. PubMed ID: 24975671
[TBL] [Abstract][Full Text] [Related]
7. Kukoamine B promotes TLR4-independent lipopolysaccharide uptake in murine hepatocytes.
Yang D; Zheng X; Wang N; Fan S; Yang Y; Lu Y; Chen Q; Liu X; Zheng J
Oncotarget; 2016 Sep; 7(36):57498-57513. PubMed ID: 27542278
[TBL] [Abstract][Full Text] [Related]
8. Targeted delivery of macromolecular drugs: asialoglycoprotein receptor (ASGPR) expression by selected hepatoma cell lines used in antiviral drug development.
Li Y; Huang G; Diakur J; Wiebe LI
Curr Drug Deliv; 2008 Oct; 5(4):299-302. PubMed ID: 18855599
[TBL] [Abstract][Full Text] [Related]
9. Asialoglycoprotein Receptor-Mediated Gene Delivery to Hepatocytes Using Galactosylated Polymers.
Thapa B; Kumar P; Zeng H; Narain R
Biomacromolecules; 2015 Sep; 16(9):3008-20. PubMed ID: 26258607
[TBL] [Abstract][Full Text] [Related]
10. Efficient Liver Targeting by Polyvalent Display of a Compact Ligand for the Asialoglycoprotein Receptor.
Sanhueza CA; Baksh MM; Thuma B; Roy MD; Dutta S; Préville C; Chrunyk BA; Beaumont K; Dullea R; Ammirati M; Liu S; Gebhard D; Finley JE; Salatto CT; King-Ahmad A; Stock I; Atkinson K; Reidich B; Lin W; Kumar R; Tu M; Menhaji-Klotz E; Price DA; Liras S; Finn MG; Mascitti V
J Am Chem Soc; 2017 Mar; 139(9):3528-3536. PubMed ID: 28230359
[TBL] [Abstract][Full Text] [Related]
11. Detection of surface asialoglycoprotein receptor expression in hepatic and extra-hepatic cells using a novel monoclonal antibody.
Park JH; Kim KL; Cho EW
Biotechnol Lett; 2006 Jul; 28(14):1061-9. PubMed ID: 16799763
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of GalNAc-siRNA Conjugate Activity in Pre-clinical Animal Models with Reduced Asialoglycoprotein Receptor Expression.
Willoughby JLS; Chan A; Sehgal A; Butler JS; Nair JK; Racie T; Shulga-Morskaya S; Nguyen T; Qian K; Yucius K; Charisse K; van Berkel TJC; Manoharan M; Rajeev KG; Maier MA; Jadhav V; Zimmermann TS
Mol Ther; 2018 Jan; 26(1):105-114. PubMed ID: 28988716
[TBL] [Abstract][Full Text] [Related]
13. The unsialylated subpopulation of recombinant activated factor VII binds to the asialo-glycoprotein receptor (ASGPR) on primary rat hepatocytes.
Seested T; Nielsen HM; Christensen EI; Appa RS
Thromb Haemost; 2010 Dec; 104(6):1166-73. PubMed ID: 20886190
[TBL] [Abstract][Full Text] [Related]
14. Design of cholesterol arabinogalactan anchored liposomes for asialoglycoprotein receptor mediated targeting to hepatocellular carcinoma: In silico modeling, in vitro and in vivo evaluation.
Pathak P; Dhawan V; Magarkar A; Danne R; Govindarajan S; Ghosh S; Steiniger F; Chaudhari P; Gopal V; Bunker A; Róg T; Fahr A; Nagarsenker M
Int J Pharm; 2016 Jul; 509(1-2):149-158. PubMed ID: 27231122
[TBL] [Abstract][Full Text] [Related]
15. ASGPR-Mediated Uptake of Multivalent Glycoconjugates for Drug Delivery in Hepatocytes.
Monestier M; Charbonnier P; Gateau C; Cuillel M; Robert F; Lebrun C; Mintz E; Renaudet O; Delangle P
Chembiochem; 2016 Apr; 17(7):590-4. PubMed ID: 26781030
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometric analysis of asialoglycoprotein receptor expression predicts hepatic functional reserve after hepatectomy.
Ke Z; Li J; Zhe J; Liang LB; Yan L; Yi M
J Coll Physicians Surg Pak; 2014 Nov; 24(11):820-4. PubMed ID: 25404440
[TBL] [Abstract][Full Text] [Related]
17. (18)F-FBHGal for asialoglycoprotein receptor imaging in a hepatic fibrosis mouse model.
Kao HW; Chen CL; Chang WY; Chen JT; Lin WJ; Liu RS; Wang HE
Bioorg Med Chem; 2013 Feb; 21(4):912-21. PubMed ID: 23321012
[TBL] [Abstract][Full Text] [Related]
18. Determination of the upper size limit for uptake and processing of ligands by the asialoglycoprotein receptor on hepatocytes in vitro and in vivo.
Rensen PC; Sliedregt LA; Ferns M; Kieviet E; van Rossenberg SM; van Leeuwen SH; van Berkel TJ; Biessen EA
J Biol Chem; 2001 Oct; 276(40):37577-84. PubMed ID: 11479285
[TBL] [Abstract][Full Text] [Related]
19. Asialoglycoprotein receptor (ASGPR) as target autoantigen in liver autoimmunity: lost and found.
Rigopoulou EI; Roggenbuck D; Smyk DS; Liaskos C; Mytilinaiou MG; Feist E; Conrad K; Bogdanos DP
Autoimmun Rev; 2012 Dec; 12(2):260-9. PubMed ID: 22571878
[TBL] [Abstract][Full Text] [Related]
20. Asialoglycoprotein receptor-targeted liposomes loaded with a norcantharimide derivative for hepatocyte-selective targeting.
Liu X; Han M; Xu J; Geng S; Zhang Y; Ye X; Gou J; Yin T; He H; Tang X
Int J Pharm; 2017 Mar; 520(1-2):98-110. PubMed ID: 28167263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
